Camelan Group was founded in 1993, under the strong support of the party committees and governments at all levels, it has developed into a modern enterprise group specializing in the production and operation of disposable medical devices for anaesthesia, pain, nursing, testing, blood purification, minimally invasive interventional, surgical, electronic intelligence, medical protection and so on, integrating research and development, production, sales, service and culture. The group has 61 production, R&D and business enterprises under it, and has set up sales subsidiaries in 31 provinces across the country. There are 5 production bases and one research institute, with more than 8000 employees and 500 disabled workers. It has a national enterprise technology center, a national demonstration platform for the production and application of biomedical materials, a national innovation center for high-performance medical devices, a key laboratory for polymer material technology and application in Henan Province, and a national industrial quality benchmark enterprise, a national industrial brand demonstration enterprise, a national industrial brand demonstration enterprise, a national industrial brand demonstration enterprise, a national industrial brand demonstration enterprise and a national industrial brand demonstration enterprise. ", "the first batch of innovative leading enterprises in Henan Province", "the first batch of manufacturing innovation centers in Henan Province" and other national and provincial honors more than 60, is the drafting unit of 12 national industry standards, the vice president of the Chinese Biomedical Engineering Society It is the drafting unit of 12 national industry standards, the vice chairman of China Biomedical Engineering Society, the chairman of China Medical Consumables Integration Union, and the chairman of Henan Medical Devices Chamber of Commerce.
Talent and innovation are the driving force of Camelot's sustainable development. The Group has a professional R&D team of more than 1,000 people, including more than 100 foreign experts, more than 20 PhDs and more than 600 masters, and invests more than 200 million yuan in R&D annually, and has undertaken 12 national, provincial and ministerial science and technology projects as well as other national projects. Since 2008, the Group has invested 7 million RMB annually for the integrated development of industry-university-research in the medical field and set up the "Camelot Medical Device Science and Technology Innovation Award" approved by the Ministry of Science and Technology of the People's Republic of China, which has become the first ministry-level project of medical device innovation award established by the Chinese social force. The new type of indwelling needles, new type of electronic infusion pumps and strengthened anesthesia catheters researched and developed by the Group have been awarded the Certificate of Scientific and Technological Achievements of Henan Province, and the Group owns more than 300 independent intellectual property rights. 2020, in order to cope with the new type of coronavirus and ensure the safety of healthcare workers and frontline personnel, Camelot Group actively undertakes the research and development projects of the Science and Technology Department of Henan Province, and develops the new type of protective hoods for medical use, the positive-pressure protective hoods for medical use, the net respiratory protection masks and the positive-pressure protective suits for medical use. The new medical protective hood, medical positive pressure protective hood, net respiratory protective mask, medical positive pressure protective clothing and other protective series products are widely used in medical clinics and social protection.
In 2019, the group realized sales revenue of 48. 6 billion yuan. The dominant product anesthesia bag domestic market share of 48%, infusion pump domestic market share of 26%, the product covers more than 12,000 hospital terminals, exported to more than 70 countries and regions around the world, in the United States, India and other international subsidiaries.
In order to help China's medical development, the group invested more than 100 million yuan in 2015 to build the country's first general medicine museum, the museum has a floor area of 6,000 square meters, by the development of China's health care history museum, medical history museum, Chinese anesthesia museum, Chinese nursing history museum, blood purification history museum and medical synthesis museum, has been completed and open to the public. on October 5, 2020, the The second phase of the Museum of China's medical device development history museum started construction, China's medical device history museum building area of 10,000 square meters, the exhibition hall to time as the main axis of the introduction of medical equipment, "evolutionary history", divided into China's medical device technology development history and China's medical device regulatory history of the two main lines, but also has a history of supervision of the provinces, China's medical device brand leaders and other sub-exhibitions. There are also sub-pavilions on the regulatory history of each province, China's medical device brand leaders and so on. The museum is now open to the public to collect relevant documents, video materials and devices with historical significance, such as drugs and other related objects. The museum establishes an interactive system integrating display, collection and exchange to provide learning opportunities for more clinical medical staff and to make more contributions to the development of Chinese medicine.
The Group actively responded to the call of the national "Healthy China", and launched the construction of Camelot Medical Device Industry New City in 2018, aiming to build a medical device ecosystem and make Changyuan the preferred place for procurement of medical device groups in China. The industrial new town invests 6 billion in 3 years, builds a 3. 5 square kilometers core area, realizes one-stop solution for medical equipment group procurement, and annual income reaches 30 billion; it invests 16 billion in 5 years, builds a 5. 2 square kilometers industrial new town, with an annual income of 50 billion, and becomes the No. 1 industrial new town in Henan Province; it accounts for 20% of exports, and influences the world. Industrial new city according to the function of setting up industrial production area, medical and pharmaceutical trade area, commercial and cultural living area and supporting services, the new city will realize the annual output value of more than 50 billion yuan after the completion of the new city. Based on the principle of "three lives" of production, life and ecology, the new industrial city will create a total solution for China's medical equipment group purchasing through the construction of a national medical equipment (protective gear) production base, a reserve base, an import and export base, and a national medical equipment (protective gear) technological innovation center, an inspection center, and a transfer center.
The future Camelot Industrial New City will be a city of innovation and technology, constantly exploring for the improvement of medical experience and the care of life and health, gathering talents from all directions, pooling the power of medical consumables, and boosting the development of a healthy China with scientific and technological innovation.
More peer-to-peer analysis, on the enterprise to know to understand